169 related articles for article (PubMed ID: 33926864)
21. Immunosuppression in solid organ-transplant recipients and impact on nutrition support.
Wilson NK; Kataria AD
Nutr Clin Pract; 2024 Feb; 39(1):109-116. PubMed ID: 38030572
[TBL] [Abstract][Full Text] [Related]
22. COVID-19 in solid organ transplant recipients: Dynamics of disease progression and inflammatory markers in ICU and non-ICU admitted patients.
Roberts MB; Izzy S; Tahir Z; Al Jarrah A; Fishman JA; El Khoury J
Transpl Infect Dis; 2020 Oct; 22(5):e13407. PubMed ID: 32654303
[TBL] [Abstract][Full Text] [Related]
23. Solid Organ Transplantation in Patients With Preexisting Malignancies in Remission: A Propensity Score Matched Cohort Study.
Acuna SA; Sutradhar R; Kim SJ; Baxter NN
Transplantation; 2018 Jul; 102(7):1156-1164. PubMed ID: 29557910
[TBL] [Abstract][Full Text] [Related]
24. Outcomes in solid organ transplant recipients with a pretransplant diagnosis of melanoma.
Zwald FO; Sargen MR; Austin AA; Hsieh MC; Pawlish K; Li J; Lynch CF; Yu KJ; Engels EA
Am J Transplant; 2024 Jun; 24(6):993-1002. PubMed ID: 38387619
[TBL] [Abstract][Full Text] [Related]
25. Risk of Rare Cancers Among Solid Organ Transplant Recipients.
D'Arcy ME; Castenson D; Lynch CF; Kahn AR; Morton LM; Shiels MS; Pfeiffer RM; Engels EA
J Natl Cancer Inst; 2021 Feb; 113(2):199-207. PubMed ID: 32462187
[TBL] [Abstract][Full Text] [Related]
26. De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population.
Miao Y; Everly JJ; Gross TG; Tevar AD; First MR; Alloway RR; Woodle ES
Transplantation; 2009 May; 87(9):1347-59. PubMed ID: 19424035
[TBL] [Abstract][Full Text] [Related]
27. De novo head and neck cancer arising in solid organ transplantation recipients: The Asan Medical Center experience.
Park MJ; Roh JL; Choi SH; Nam SY; Kim SY; Lee YS
Auris Nasus Larynx; 2018 Aug; 45(4):838-845. PubMed ID: 29150348
[TBL] [Abstract][Full Text] [Related]
28. Risk of Kaposi sarcoma after solid organ transplantation in the United States.
Cahoon EK; Linet MS; Clarke CA; Pawlish KS; Engels EA; Pfeiffer RM
Int J Cancer; 2018 Dec; 143(11):2741-2748. PubMed ID: 29987894
[TBL] [Abstract][Full Text] [Related]
29. Cumulative incidence of cancer after solid organ transplantation.
Hall EC; Pfeiffer RM; Segev DL; Engels EA
Cancer; 2013 Jun; 119(12):2300-8. PubMed ID: 23559438
[TBL] [Abstract][Full Text] [Related]
30. Risk of lip cancer after solid organ transplantation in the United States.
Laprise C; Cahoon EK; Lynch CF; Kahn AR; Copeland G; Gonsalves L; Madeleine MM; Pfeiffer RM; Engels EA
Am J Transplant; 2019 Jan; 19(1):227-237. PubMed ID: 30074684
[TBL] [Abstract][Full Text] [Related]
31. Risk of merkel cell carcinoma after solid organ transplantation.
Clarke CA; Robbins HA; Tatalovich Z; Lynch CF; Pawlish KS; Finch JL; Hernandez BY; Fraumeni JF; Madeleine MM; Engels EA
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25575645
[TBL] [Abstract][Full Text] [Related]
32. Melanoma Risk and Survival among Organ Transplant Recipients.
Robbins HA; Clarke CA; Arron ST; Tatalovich Z; Kahn AR; Hernandez BY; Paddock L; Yanik EL; Lynch CF; Kasiske BL; Snyder J; Engels EA
J Invest Dermatol; 2015 Nov; 135(11):2657-2665. PubMed ID: 26270022
[TBL] [Abstract][Full Text] [Related]
33. Is thyroid cancer prognosis affected by solid organ transplantation?
Webb C; Cronin P; Gupta N; Verhey J; Calderon E; Moss A; Mathur AK; Pockaj B; Wasif N; Stucky CC
Surgery; 2021 Jan; 169(1):58-62. PubMed ID: 32814633
[TBL] [Abstract][Full Text] [Related]
34. Cancer stage at diagnosis in patients infected with the human immunodeficiency virus and transplant recipients.
Shiels MS; Copeland G; Goodman MT; Harrell J; Lynch CF; Pawlish K; Pfeiffer RM; Engels EA
Cancer; 2015 Jun; 121(12):2063-71. PubMed ID: 25739496
[TBL] [Abstract][Full Text] [Related]
35. Clostridioides difficile infection and recurrence among 2622 solid organ transplant recipients.
Schluger A; Rosenblatt R; Knotts R; Verna EC; Pereira MR
Transpl Infect Dis; 2019 Dec; 21(6):e13184. PubMed ID: 31571380
[TBL] [Abstract][Full Text] [Related]
36. Cancer Mortality Among Solid Organ Transplant Recipients in the United States During 1987-2018.
Wang JH; Pfeiffer RM; Musgrove D; Castenson D; Fredrickson M; Miller J; Gonsalves L; Hsieh MC; Lynch CF; Zeng Y; Yu KJ; Hart A; Israni AK; Snyder JJ; Engels EA
Transplantation; 2023 Nov; 107(11):2433-2442. PubMed ID: 37291711
[TBL] [Abstract][Full Text] [Related]
37. Survival Associated With Sirolimus Plus Tacrolimus Maintenance Without Induction Therapy Compared With Standard Immunosuppression After Lung Transplant.
Wijesinha M; Hirshon JM; Terrin M; Magder L; Brown C; Stafford K; Iacono A
JAMA Netw Open; 2019 Aug; 2(8):e1910297. PubMed ID: 31461151
[TBL] [Abstract][Full Text] [Related]
38. Antithymocyte Globulin Versus Interleukin-2 Receptor Antagonist in Kidney Transplant Recipients With Hepatitis C Virus.
Bae S; Durand CM; Garonzik-Wang JM; Chow EKH; Kucirka LM; McAdams-DeMarco MA; Massie AB; Al Ammary F; Coresh J; Segev DL
Transplantation; 2020 Jun; 104(6):1294-1303. PubMed ID: 32433232
[TBL] [Abstract][Full Text] [Related]
39. Malignancy: An Adverse Effect of Immunosuppression.
Munagala M; Phancao A
Handb Exp Pharmacol; 2022; 272():315-335. PubMed ID: 34697663
[TBL] [Abstract][Full Text] [Related]
40. Risk of myeloid neoplasms after solid organ transplantation.
Morton LM; Gibson TM; Clarke CA; Lynch CF; Anderson LA; Pfeiffer R; Landgren O; Weisenburger DD; Engels EA
Leukemia; 2014 Dec; 28(12):2317-23. PubMed ID: 24727673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
